Allmed Medical Products Co.,Ltd

SZSE:002950 Stock Report

Market Cap: CN¥5.1b

Allmed Medical ProductsLtd Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Allmed Medical ProductsLtd.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Medical Equipment earnings growth26.6%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

Allmed Medical ProductsLtd's (SZSE:002950) Weak Earnings May Only Reveal A Part Of The Whole Picture

Nov 06
Allmed Medical ProductsLtd's (SZSE:002950) Weak Earnings May Only Reveal A Part Of The Whole Picture

Pinning Down Allmed Medical Products Co.,Ltd's (SZSE:002950) P/E Is Difficult Right Now

Sep 29
Pinning Down Allmed Medical Products Co.,Ltd's (SZSE:002950) P/E Is Difficult Right Now

Allmed Medical ProductsLtd (SZSE:002950) Is Paying Out Less In Dividends Than Last Year

Jun 16
Allmed Medical ProductsLtd (SZSE:002950) Is Paying Out Less In Dividends Than Last Year

Little Excitement Around Allmed Medical Products Co.,Ltd's (SZSE:002950) Revenues

Jun 07
Little Excitement Around Allmed Medical Products Co.,Ltd's (SZSE:002950) Revenues

There May Be Some Bright Spots In Allmed Medical ProductsLtd's (SZSE:002950) Earnings

May 06
There May Be Some Bright Spots In Allmed Medical ProductsLtd's (SZSE:002950) Earnings

Allmed Medical ProductsLtd (SZSE:002950) May Have Issues Allocating Its Capital

Apr 30
Allmed Medical ProductsLtd (SZSE:002950) May Have Issues Allocating Its Capital

Allmed Medical ProductsLtd (SZSE:002950) Has A Pretty Healthy Balance Sheet

Feb 27
Allmed Medical ProductsLtd (SZSE:002950) Has A Pretty Healthy Balance Sheet

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Allmed Medical ProductsLtd has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

SZSE:002950 - Analysts future estimates and past financials data (CNY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/20243,188225274481N/A
6/30/20242,912140316544N/A
3/31/20242,68876400630N/A
12/31/20232,757110137424N/A
9/30/20233,162360561708N/A
6/30/20233,503274534798N/A
3/31/20234,032377381800N/A
1/1/20234,2114077521,150N/A
9/30/20223,6652997061,036N/A
6/30/20223,563484665864N/A
3/31/20223,098473513692N/A
1/1/20222,92643184375N/A
9/30/20213,07352888517N/A
6/30/20213,076684190659N/A
3/31/20214,0581,1836991,099N/A
12/31/20203,8341,1581,1931,437N/A
9/30/20203,7301,0671,0421,297N/A
6/30/20203,5139268131,056N/A
3/31/20202,436362513696N/A
12/31/20192,35232641273N/A
9/30/20192,291305-24248N/A
6/30/20192,220253-170120N/A
3/31/20192,135242-338-34N/A
12/31/20182,028228-2843N/A
12/31/20171,711234N/A197N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if 002950's forecast earnings growth is above the savings rate (2.8%).

Earnings vs Market: Insufficient data to determine if 002950's earnings are forecast to grow faster than the CN market

High Growth Earnings: Insufficient data to determine if 002950's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if 002950's revenue is forecast to grow faster than the CN market.

High Growth Revenue: Insufficient data to determine if 002950's revenue is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 002950's Return on Equity is forecast to be high in 3 years time


Discover growth companies